These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7381692)

  • 41. Con-Current versus Counter-Current Dialysate Flow during CVVHD. A Comparative Study for Creatinine and Urea Removal.
    Baldwin I; Baldwin M; Fealy N; Neri M; Garzotto F; Kim JC; Giuliani A; Basso F; Nalesso F; Brendolan A; Ronco C
    Blood Purif; 2016; 41(1-3):171-6. PubMed ID: 26764970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodialysis blood access flow rates can be estimated accurately from on-line dialysate urea measurements and the knowledge of effective dialyzer urea clearance.
    Lindsay RM; Sternby J; Olde B; Persson R; Thatcher ME; Sargent K
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):960-4. PubMed ID: 17699313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance.
    Uhlin F; Fridolin I; Magnusson M; Lindberg LG
    Nephrol Dial Transplant; 2006 Aug; 21(8):2225-31. PubMed ID: 16611681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study.
    Leypoldt JK; Cheung AK; Agodoa LY; Daugirdas JT; Greene T; Keshaviah PR
    Kidney Int; 1997 Jun; 51(6):2013-7. PubMed ID: 9186896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy.
    Dhondt AW; Vanholder RC; De Smet RV; Claus SA; Waterloos MA; Glorieux GL; Delanghe JR; Lameire NH
    Kidney Int; 2003 Apr; 63(4):1540-7. PubMed ID: 12631371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodialysis clearance of theophylline.
    Slaughter RL; Green L; Kohli R
    Ther Drug Monit; 1982; 4(2):191-3. PubMed ID: 7101387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dialysate calcium loss using a calcium free dialysate.
    Kaye M
    Int J Artif Organs; 1994 Jul; 17(7):365-72. PubMed ID: 7806422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
    Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
    Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis.
    Blum RA; Olson SC; Kohli RK; Horvath AM; Sedman AJ; Posvar EL
    J Clin Pharmacol; 1990 Oct; 30(10):938-42. PubMed ID: 2229454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Removal of phenytoin by hemodialysis in uremic patients.
    Martin E; Gambertoglio JG; Adler DS; Tozer TN; Roman LA; Grausz H
    JAMA; 1977 Oct; 238(16):1750-3. PubMed ID: 578272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetics of oral ethambutol in the normal subject.
    Lee CS; Gambertoglio JG; Brater DC; Benet LZ
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):615-21. PubMed ID: 410579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodialysis of phenytoin in a uremic patient.
    Adler DS; Martin E; Gambertoglio JG; Tozer TN; Spire JP
    Clin Pharmacol Ther; 1975 Jul; 18(1):65-9. PubMed ID: 1149364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of hemodialysis on piperacillin pharmacokinetics.
    Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethambutol kinetics in patients with impaired renal function.
    Varughese A; Brater DC; Benet LZ; Lee CS
    Am Rev Respir Dis; 1986 Jul; 134(1):34-8. PubMed ID: 3729159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accuracy of hemodialysis modeling.
    Ziółko M; Pietrzyk JA; Grabska-Chrzastowska J
    Kidney Int; 2000 Mar; 57(3):1152-63. PubMed ID: 10720967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes.
    Meyer TW; Leeper EC; Bartlett DW; Depner TA; Lit YZ; Robertson CR; Hostetter TH
    J Am Soc Nephrol; 2004 Jul; 15(7):1927-35. PubMed ID: 15213283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonlinear plasma protein binding and haemodialysis clearance of prednisolone.
    Frey FJ; Gambertoglio JG; Frey BM; Benet LZ; Amend WJ
    Eur J Clin Pharmacol; 1982; 23(1):65-74. PubMed ID: 6751835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.